Hypothesis

Age‑related decline in astrocytic GLT‑1 (EAAT2) expression in the central amygdala produces chronic low‑level glutamate spillover that selectively depresses NMDA receptor signaling in CRF‑expressing neurons. This NMDA hypofunction triggers a homeostatic increase in AMPA receptor subunits and CREB‑dependent transcription, stabilizing fear traces and impairing extinction. Restoring astrocytic glutamate uptake will rebalance NMDA/AMPA signaling in CRF neurons and rescue extinction learning without altering baseline anxiety.

Mechanistic Rationale

NMDA receptor hypofunction in CRF neurons has been shown to up‑regulate Gria1/AMPA and Creb1, strengthening fear memories ([2]). Concurrently, loss of GABA(A)α1‑mediated inhibition in these cells heightens anxiety and blocks extinction, a defect rescued by CRF antagonists ([3]). The shift from NMDA to AMPA dominance therefore creates a rigid, over‑consolidated fear trace that resists vmPFC‑mediated safety learning. Astrocytic glutamate transporters normally limit extrasynaptic glutamate; their reduction with age has been linked to altered synaptic plasticity in other regions. If GLT‑1 loss is pronounced in the central amygdala, it would produce the exact NMDA‑low/AMPA‑high state observed in CRF neurons after Grin1 deletion, providing a cell‑type‑specific mechanism for the aging‑related extinction deficit.

Testable Predictions

1. Aged mice will show decreased GLT‑1 protein and mRNA specifically in astrocytes surrounding CRF+ neurons in the central amygdala, while total amygdala GLT‑1 remains unchanged.
2. This reduction will correlate with elevated extracellular glutamate measured by microdialysis and reduced NMDA‑mediated currents in CRF+ neurons (patch‑clamp).
3. Pharmacological up‑regulation of GLT‑1 (e.g., ceftriaxone) or chemogenetic activation of astrocytes (hM3Dq) in aged mice will normalize NMDA/AMPA ratios in CRF+ neurons and improve fear extinction, without affecting baseline anxiety levels measured in the elevated plus maze.
4. Conversely, astrocyte‑specific knock‑down of GLT‑1 in young adult mice will mimic the aged phenotype: NMDA hypofunction, AMPA up‑regulation in CRF+ neurons, and extinction impairment.

Experimental Approach

• Use CRF‑Cre mice crossed with a fluorescent reporter to isolate CRF+ neurons from the central amygdala of young (3 mo) and aged (18–24 mo) mice.
• Perform qPCR and Western blot for GLT‑1 in FACS‑sorted astrocytes (ACSA2+) versus neurons.
• Measure basal extracellular glutamate with enzyme‑based biosensors in amygdala slices.
• Record NMDA and AMPA evoked currents in visually identified CRF+ neurons via whole‑cell patch clamp.
• Administer ceftriaxone (200 mg/kg, i.p., daily for 7 days) or express hM3Dq in astrocytes using AAV5‑GFAP‑hM3Dq‑mCherry; activate with CNO (1 mg/kg, i.p.) during extinction training.
• Assess fear conditioning and extinction (freezing %) and anxiety (elevated plus maze, open field).
• Include controls: vehicle, CNO‑only, and CRF‑antagonist (antalarmin) groups to isolate contributions.

Potential Outcomes and Interpretation

If aged mice exhibit astrocytic GLT‑1 loss correlated with NMDA hypofunction/AMPA up‑regulation in CRF+ neurons, and GLT‑1 restoration rescues extinction, the hypothesis is supported. This would indicate that aging‑related fear rigidity stems from a glial‑mediated glutamate imbalance rather than neuronal decay, suggesting that enhancing astrocytic glutamate clearance can reopen plasticity windows in maladaptive fear circuits. Failure to observe GLT‑1 changes or lack of rescue would falsify the mechanism, prompting investigation of alternative cell‑specific pathways (e.g., microglial cytokine signaling or perineuronal net alterations) underlying the NMDA‑AMPA shift in aging CRF neurons.